-
1
-
-
33847287323
-
Juvenile idiopathic arthritis
-
Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
-
(2007)
Lancet
, vol.369
, pp. 767-778
-
-
Ravelli, A.1
Martini, A.2
-
2
-
-
77950512831
-
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: A randomized clinical trial
-
Foell D, Wulffraat N, Wedderburn LR, et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial. JAMA 2010;303:1266-73.
-
(2010)
JAMA
, vol.303
, pp. 1266-1273
-
-
Foell, D.1
Wulffraat, N.2
Wedderburn, L.R.3
-
3
-
-
3142746016
-
A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate
-
DOI 10.1002/art.20288
-
Ruperto N, Murray KJ, Gerloni V, et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 2004;50:2191-201. (Pubitemid 38924397)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.7
, pp. 2191-2201
-
-
Ruperto, N.1
Murray, K.J.2
Gerloni, V.3
Wulffraat, N.4
De Oliveira, S.K.F.5
Falcini, F.6
Dolezalova, P.7
Alessio, M.8
Burgos-Vargas, R.9
Corona, F.10
Vesely, R.11
Foster, H.12
Davidson, J.13
Zulian, F.14
Asplin, L.15
Baildam, E.16
Consuegra, J.G.17
Ozdogan, H.18
Saurenmann, R.19
Joos, R.20
Pistorio, A.21
Woo, P.22
Martini, A.23
more..
-
5
-
-
0034673697
-
Etanercept in children with polyarticular juvenile rheumatoid arthritis
-
DOI 10.1056/NEJM200003163421103
-
Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000;342:763-9. (Pubitemid 30151920)
-
(2000)
New England Journal of Medicine
, vol.342
, Issue.11
, pp. 763-769
-
-
Lovell, D.J.1
Giannini, E.H.2
Reiff, A.3
Cawkwell, G.D.4
Silverman, E.D.5
Nocton, J.J.6
Stein, L.D.7
Gedalia, A.8
Ilowite, N.T.9
Wallace, C.A.10
Whitmore, J.11
Finck, B.K.12
-
6
-
-
34848884299
-
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
-
DOI 10.1002/art.22838
-
Ruperto N, Lovell DJ, Cuttica R, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2007;56:3096-106. (Pubitemid 47502757)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.9
, pp. 3096-3106
-
-
Ruperto, N.1
Lovell, D.J.2
Cuttica, R.3
Wilkinson, N.4
Woo, P.5
Espada, G.6
Wouters, C.7
Silverman, E.D.8
Balogh, Z.9
Henrickson, M.10
Apaz, M.-T.11
Baildam, E.12
Fasth, A.13
Gerloni, V.14
Lahdenne, P.15
Prieur, A.-M.16
Ravelli, A.17
Saurenmann, R.K.18
Gamir, M.L.19
Wulffraat, N.20
Marodi, L.21
Petty, R.E.22
Joos, R.23
Zulian, F.24
McCurdy, D.25
Myones, B.L.26
Nagy, K.27
Reuman, P.28
Szer, I.29
Travers, S.30
Beutler, A.31
Keenan, G.32
Clark, J.33
Visvanathan, S.34
Fasanmade, A.35
Raychaudhuri, A.36
Mendelsohn, A.37
Martini, A.38
Giannini, E.H.39
more..
-
7
-
-
78249256670
-
The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis
-
Swart JF, Barug D, Möhlmann M, et al. The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis. Expert Opin Biol Ther 2010;10:1743-52.
-
(2010)
Expert Opin Biol Ther
, vol.10
, pp. 1743-1752
-
-
Swart, J.F.1
Barug, D.2
Möhlmann, M.3
-
8
-
-
66149142293
-
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: The Dutch national register
-
Prince FH, Twilt M, ten Cate R, et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis 2009;68:635-41.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 635-641
-
-
Prince, F.H.1
Twilt, M.2
Ten Cate, R.3
-
9
-
-
70350449256
-
New advances in the management of juvenile idiopathic arthritis-2: The era of biologicals
-
Beresford MW, Baildam EM. New advances in the management of juvenile idiopathic arthritis-2: the era of biologicals. Arch Dis Child Educ Pract Ed 2009;94:151-6.
-
(2009)
Arch Dis Child Educ Pract Ed
, vol.94
, pp. 151-156
-
-
Beresford, M.W.1
Baildam, E.M.2
-
10
-
-
79955670864
-
Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis
-
Mircic M, Kavanaugh A. Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis. Exp Cell Res 2011;317:1286-92.
-
(2011)
Exp Cell Res
, vol.317
, pp. 1286-1292
-
-
Mircic, M.1
Kavanaugh, A.2
-
11
-
-
80051470174
-
Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): A multicentre randomised open-label clinical trial
-
Tynjälä P, Vähäsalo P, Tarkiainen M, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann Rheum Dis 2011;70:1605-12.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 1605-1612
-
-
Tynjälä, P.1
Vähäsalo, P.2
Tarkiainen, M.3
-
12
-
-
77957584399
-
The safety profile of biologic therapies for juvenile idiopathic arthritis
-
Hashkes PJ, Uziel Y, Laxer RM. The safety profile of biologic therapies for juvenile idiopathic arthritis. Nat Rev Rheumatol 2010;6:561-71.
-
(2010)
Nat Rev Rheumatol
, vol.6
, pp. 561-571
-
-
Hashkes, P.J.1
Uziel, Y.2
Laxer, R.M.3
-
13
-
-
77955738020
-
Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: A French retrospective study
-
Dallocchio A, Canioni D, Ruemmele F, et al. Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study. Rheumatology (Oxford) 2010;49:1694-8.
-
(2010)
Rheumatology (Oxford)
, vol.49
, pp. 1694-1698
-
-
Dallocchio, A.1
Canioni, D.2
Ruemmele, F.3
-
14
-
-
77955371398
-
Tumor necrosis factor alpha blockers and malignancy in children: Forty-eight cases reported to the Food and Drug Administration
-
Diak P, Siegel J, La Grenade L, et al. Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis Rheum 2010;62:2517-24.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 2517-2524
-
-
Diak, P.1
Siegel, J.2
La Grenade, L.3
-
15
-
-
65249098979
-
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): Preliminary data from the German JIA Registry
-
Horneff G, De Bock F, Foeldvari I, et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 2009;68:519-25.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 519-525
-
-
Horneff, G.1
De Bock, F.2
Foeldvari, I.3
-
16
-
-
78650990577
-
Pediatric rheumatology: JIA, treatment and possible risk of malignancies
-
Ruperto N, Martini A. Pediatric rheumatology: JIA, treatment and possible risk of malignancies. Nat Rev Rheumatol 2011;7:6-7.
-
(2011)
Nat Rev Rheumatol
, vol.7
, pp. 6-7
-
-
Ruperto, N.1
Martini, A.2
-
17
-
-
34447508090
-
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis
-
DOI 10.1002/art.22640
-
Wessels JA, van der Kooij SM, le Cessie S, et al. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis Rheum 2007;56:1765-75. (Pubitemid 47110376)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.6
, pp. 1765-1775
-
-
Wessels, J.A.M.1
Van Der, K.S.M.2
Le, C.S.3
Kievit, W.4
Barerra, P.5
Allaart, C.F.6
Huizinga, T.W.J.7
Guchelaar, H.-J.8
-
18
-
-
10744230484
-
International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: Second Revision, Edmonton, 2001
-
Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2. (Pubitemid 38160763)
-
(2004)
Journal of Rheumatology
, vol.31
, Issue.2
, pp. 390-392
-
-
Petty, R.E.1
Southwood, T.R.2
Manners, P.3
Baum, J.4
Glass, D.N.5
Goldenberg, J.6
He, X.7
Maldonado-Cocco, J.8
Orozco-Alcala, J.9
Prieur, A.-M.10
Suarez-Almazor, M.E.11
Woo, P.12
-
19
-
-
15444352940
-
Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate
-
Ruperto N, Ravelli A, Falcini F, et al. Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ann Rheum Dis 1998;57:38-41. (Pubitemid 28175218)
-
(1998)
Annals of the Rheumatic Diseases
, vol.57
, Issue.1
, pp. 38-41
-
-
Ruperto, N.1
Ravelli, A.2
Falcini, F.3
Lepore, L.4
De Sanctis, R.5
Zulian, F.6
Buoncompagni, A.7
Sardella, M.L.8
Strano, C.9
Alessio, M.10
Viola, S.11
Martini, A.12
-
20
-
-
0030960980
-
Preliminary definition of improvement in juvenile arthritis
-
Giannini EH, Ruperto N, Ravelli A, et al. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9. (Pubitemid 27430130)
-
(1997)
Arthritis and Rheumatism
, vol.40
, Issue.7
, pp. 1202-1209
-
-
Giannini, E.H.1
Ruperto, N.2
Ravelli, A.3
Lovell, D.J.4
Felson, D.T.5
Martini, A.6
-
21
-
-
0035404474
-
The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ)
-
Wulffraat N, van der Net JJ, Ruperto N, et al. The Dutch version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001;19(4 Suppl 23):S111-5.
-
(2001)
Clin Exp Rheumatol
, vol.19
, Issue.4 SUPPL. 23
-
-
Wulffraat, N.1
Van Der Net, J.J.2
Ruperto, N.3
-
22
-
-
77953495664
-
Do snapshot statistics fool us in MTX pharmacogenetic studies in arthritis research?
-
de Rotte MC, Luime JJ, Bulatovic M, et al. Do snapshot statistics fool us in MTX pharmacogenetic studies in arthritis research? Rheumatology (Oxford) 2010;49:1200-1.
-
(2010)
Rheumatology (Oxford)
, vol.49
, pp. 1200-1201
-
-
De Rotte, M.C.1
Luime, J.J.2
Bulatovic, M.3
-
23
-
-
58349116270
-
Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis
-
Albers HM, Wessels JA, van der Straaten RJ, et al. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Rheum 2009;61:46-51.
-
(2009)
Arthritis Rheum
, vol.61
, pp. 46-51
-
-
Albers, H.M.1
Wessels, J.A.2
Van Der Straaten, R.J.3
-
24
-
-
77955450480
-
Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: Analysis of the PRINTO methotrexate trial
-
Vilca I, Munitis PG, Pistorio A, et al. Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial. Ann Rheum Dis 2010;69:1479-83.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1479-1483
-
-
Vilca, I.1
Munitis, P.G.2
Pistorio, A.3
-
25
-
-
0033503925
-
The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis
-
Ravelli A, Viola S, Migliavacca D, et al. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. J Pediatr 1999;135:316-20. (Pubitemid 30180504)
-
(1999)
Journal of Pediatrics
, vol.135
, Issue.3
, pp. 316-320
-
-
Ravelli, A.1
Viola, S.2
Migliavacca, D.3
Ruperto, N.4
Pistorio, A.5
Martini, A.6
-
26
-
-
0033875824
-
Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis
-
Woo P, Southwood TR, Prieur AM, et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000;43:1849-57.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 1849-1857
-
-
Woo, P.1
Southwood, T.R.2
Prieur, A.M.3
-
27
-
-
0026609159
-
Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial
-
The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group
-
Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med 1992;326:1043-9.
-
(1992)
N Engl J Med
, vol.326
, pp. 1043-1049
-
-
Giannini, E.H.1
Brewer, E.J.2
Kuzmina, N.3
-
28
-
-
0028269801
-
Factors associated with response to methotrexate in systemic-onset juvenile chronic arthritis
-
Ravelli A, Ramenghi B, Di Fuccia G, et al. Factors associated with response to methotrexate in systemic-onset juvenile chronic arthritis. Acta Paediatr 1994;83:428-32. (Pubitemid 24136715)
-
(1994)
Acta Paediatrica, International Journal of Paediatrics
, vol.83
, Issue.4
, pp. 428-432
-
-
Ravelli, A.1
Ramenghi, B.2
Di, F.G.3
Ruperto, N.4
Zonta, L.5
Martini, A.6
-
29
-
-
39549121704
-
The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis
-
DOI 10.1136/ard.2007.073445
-
Bartoli M, Tarò M, Magni-Manzoni S, et al. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. Ann Rheum Dis 2008;67:370-4. (Pubitemid 351281273)
-
(2008)
Annals of the Rheumatic Diseases
, vol.67
, Issue.3
, pp. 370-374
-
-
Bartoli, M.1
Taro, M.2
Magni-Manzoni, S.3
Pistorio, A.4
Traverso, F.5
Viola, S.6
Magnani, A.7
Gasparini, C.8
Martini, A.9
Ravelli, A.10
-
30
-
-
75749134134
-
Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis
-
Albers HM, Brinkman DM, Kamphuis SS, et al. Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2010;62:204-12.
-
(2010)
Arthritis Care Res (Hoboken)
, vol.62
, pp. 204-212
-
-
Albers, H.M.1
Brinkman, D.M.2
Kamphuis, S.S.3
-
31
-
-
4544372922
-
The MDR1 3435 polymorphism in patients with rheumatoid arthritis
-
Pawlik A, Wrzesniewska J, Fiedorowicz-Fabrycy I, et al. The MDR1 3435 polymorphism in patients with rheumatoid arthritis. Int J Clin Pharmacol Ther 2004;42:496-503. (Pubitemid 39255621)
-
(2004)
International Journal of Clinical Pharmacology and Therapeutics
, vol.42
, Issue.9
, pp. 496-503
-
-
Pawlik, A.1
Wrzesniewska, J.2
Fiedorowicz-Fabrycy, I.3
Gawronska-Szklarz, B.4
-
32
-
-
47349093732
-
Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis
-
DOI 10.1038/jid.2008.16, PII JID200816
-
Warren RB, Smith RL, Campalani E, et al. Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis. J Invest Dermatol 2008;128:1925-9. (Pubitemid 352001201)
-
(2008)
Journal of Investigative Dermatology
, vol.128
, Issue.8
, pp. 1925-1929
-
-
Warren, R.B.1
Smith, R.Ll.2
Campalani, E.3
Eyre, S.4
Smith, C.H.5
Barker, J.N.W.N.6
Worthington, J.7
Griffiths, C.E.M.8
-
33
-
-
22144446041
-
Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia
-
DOI 10.1182/blood-2004-12-4941
-
de Jonge R, Hooijberg JH, van Zelst BD, et al. Effect of polymorphisms in folate-related genes on in vitro methotrexate sensitivity in pediatric acute lymphoblastic leukemia. Blood 2005;106:717-20. (Pubitemid 40981271)
-
(2005)
Blood
, vol.106
, Issue.2
, pp. 717-720
-
-
De Jonge, R.1
Hooijberg, J.H.2
Van Zelst, B.D.3
Jansen, G.4
Van Zantwijk, C.H.5
Kaspers, G.J.L.6
Peters, F.G.J.7
Ravindranath, Y.8
Pieters, R.9
Lindemans, J.10
|